相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multidrug evolutionary strategies to reverse antibiotic resistance
Michael Baym et al.
SCIENCE (2016)
Dry powder inhalable formulations for anti-tubercular therapy
Thaigarajan Parumasivam et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
Computational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome
Simeone Marino et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
In silico evaluation and exploration of antibiotic tuberculosis treatment regimens
Elsje Pienaar et al.
BMC SYSTEMS BIOLOGY (2015)
The anti-tuberculosis agents under development and the challenges ahead
Deepak Kumar et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses
Anne Lenaerts et al.
IMMUNOLOGICAL REVIEWS (2015)
A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
Elsje Pienaar et al.
JOURNAL OF THEORETICAL BIOLOGY (2015)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
Treatment of Tuberculosis
C. Robert Horsburgh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Variability in Tuberculosis Granuloma T Cell Responses Exists, but a Balance of Pro- and Anti-inflammatory Cytokines Is Associated with Sterilization
Hannah Priyadarshini Gideon et al.
PLOS PATHOGENS (2015)
Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents
Suresh B. Lakshminarayana et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity-Mediated Antimicrobial Responses with Caseation during Mycobacterium tuberculosis Infection
Nicholas A. Cilfone et al.
JOURNAL OF IMMUNOLOGY (2015)
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Alimuddin I. Zumla et al.
LANCET INFECTIOUS DISEASES (2014)
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
Philana Ling Lin et al.
NATURE MEDICINE (2014)
The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
Veronique Dartois
NATURE REVIEWS MICROBIOLOGY (2014)
A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
Corinne S. Merle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
Stephen H. Gillespie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
Ray Y. Chen et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis
Won-Jung Koh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study
Rui-Hua Jiang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection
Nicholas A. Cilfone et al.
PLOS ONE (2013)
Adherence to Medications: Insights Arising from Studies on the Unreliable Link Between Prescribed and Actual Drug Dosing Histories
Terrence F. Blaschke et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Two-Drug Antimicrobial Chemotherapy: A Mathematical Model and Experiments with Mycobacterium marinum
Peter Ankomah et al.
PLOS PATHOGENS (2012)
Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model
Rosa Cremades et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Multiscale Computational Modeling Reveals a Critical Role for TNF-α Receptor 1 Dynamics in Tuberculosis Granuloma Formation
Mohammad Fallahi-Sichani et al.
JOURNAL OF IMMUNOLOGY (2011)
Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy
Caroline Colijn et al.
PLOS ONE (2011)
Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response
Selvakumar Subbian et al.
OPEN BIOLOGY (2011)
Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
Jinwoo Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2011)
Synthesis and antitubercular evaluation of new fluoroquinolone derivatives coupled with carbohydrates
Mauricio F. Saraiva et al.
CARBOHYDRATE RESEARCH (2010)
Neutrophils Are the Predominant Infected Phagocytic Cells in the Airways of Patients With Active Pulmonary TB
Seok-Yong Eum et al.
CHEST (2010)
Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
Philana Ling Lin et al.
INFECTION AND IMMUNITY (2009)
Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection
J. Christian J. Ray et al.
JOURNAL OF IMMUNOLOGY (2009)
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
Marcus B. Conde et al.
LANCET (2009)
A replication clock for Mycobacterium tuberculosis
Wendy P. Gill et al.
NATURE MEDICINE (2009)
Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates
Laura E. Via et al.
INFECTION AND IMMUNITY (2008)
NF-κB activation controls phagolysosome fusion-mediated killing of mycobacteria by macrophages
Maximiliano Gabriel Gutierrez et al.
JOURNAL OF IMMUNOLOGY (2008)
Tumor Necrosis Factor Blockers Influence Macrophage Responses to Mycobacterium tuberculosis
James Harris et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding
Nigel J. Waters et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
A methodology for performing global uncertainty and sensitivity analysis in systems biology
Simeone Marino et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
The early bactericidal activity of anti-tuberculosis drugs: a literature review
P. R. Donald et al.
TUBERCULOSIS (2008)
Medication compliance and persistence: Terminology and definitions
Joyce A. Cramer et al.
VALUE IN HEALTH (2008)
Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis
Charles A. Peloquin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis
William J. Burman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Potent twice-weekly rifapentine-containing regimens in murine tuberculosis
Ian M. Rosenthal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Early events in Mycobacterium tuberculosis infection in cynomolgus macaques
Philana Ling Lin et al.
INFECTION AND IMMUNITY (2006)
Functional classification of drugs by properties of their pairwise interactions
P Yeh et al.
NATURE GENETICS (2006)
Emergence of fluoroquinolone resistance in Mycobacterium tuberculosis during continuously dosed moxifloxacin monotherapy in a mouse model
AS Ginsburg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Mutant prevention concentration:: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis
JC Rodríguez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults
B Capitano et al.
CHEST (2004)
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis
EL Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Identifying control mechanisms of granuloma formation during M-tuberculosis infection using an agent-based model
JL Segovia-Juarez et al.
JOURNAL OF THEORETICAL BIOLOGY (2004)
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis
EL Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Pharmacodynamic functions: A multiparameter approach to the design of antibiotic treatment regimens
RR Regoes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Experimental Mycobacterium tuberculosis infection of cynomolgus Macaques closely resembles the various manifestations of human M-tuberculosis infection
SV Capuano et al.
INFECTION AND IMMUNITY (2003)
Comparative antimicrobial activities of gatifloxacin, sitafloxacin and levofloxacin against Mycobacterium tuberculosis replicating within Mono Mac 6 human macrophage and A-549 type II alveolar cell lines
K Sato et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Illustration of sampling-based methods for uncertainty and sensitivity analysis
JC Helton et al.
RISK ANALYSIS (2002)
Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice
N Lounis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Predicting the outcome of therapy for pulmonary tuberculosis
RS Wallis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
